Leap Therapeutics

About:

Leap Therapeutics is a clinical-stage biopharmaceutical company for development of targeted and immuno-oncology therapeutics.

Website: http://www.leaptx.com

Twitter/X: leaptherapeutic

Top Investors: Samsara BioCapital, Gilead Sciences, BeiGene, Eli Lilly & Company Foundation, Rock Springs Capital

Description:

Leap Therapeutics is a clinical-stage biopharmaceutical company and specializes in the development of targeted and immuno-oncology therapeutics. Leap Therapeutic focus is to identify translational-stage molecules in the areas of cell signaling and immuno-oncology.

Total Funding Amount:

$267M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2011-01-01

Contact Email:

info(AT)leaptx.com

Founders:

Douglas E. Onsi

Number of Employees:

11-50

Last Funding Date:

2024-04-10

IPO Status:

Public

Industries:

© 2025 bioDAO.ai